1109. Valgancyclovir Dosing for Cytomegalovirus Prophylaxis in Heart Transplant Recipients

BACKGROUND: Cytomegalovirus (CMV) is one of the most common infections after transplantation and continues to cause significant morbidity and mortality. Current guidelines recommend 3-6 months of post-transplant prophylaxis with 900mg daily of valganciclovir in heart transplant recipients. At our in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Open Forum Infect Dis
Autores principales: Huang, Glen, Davis, Matthew R, Beaird, Omer E, Carlson, Margrit, Gaynor, Pryce, Multani, Ashrit, Deng, Mario, Nsair, Ali, Schaenman, Joanna M
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7776552/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa439.1295
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares